What is Stokes Pharmacy?
Founded in 1975, Stokes Pharmacy is a distinguished provider of compounded medications tailored for both human and veterinary applications. The company focuses on enhancing patient outcomes through a diverse portfolio that includes treatments for conditions like feline infectious peritonitis (FIP) and a comprehensive range of equine medications. Serving a broad clientele from pet owners and veterinary practices to individual human patients, Stokes Pharmacy has built a reputation for unwavering commitment to quality, safety, and the efficacy of its preparations. Their operational excellence is further characterized by efficient delivery services and superior customer support, all while adhering to stringent quality control measures to ensure every prescription meets the highest standards.
How much funding has Stokes Pharmacy raised?
Stokes Pharmacy has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Stokes Pharmacy?
The recent major strategic investment into Stokes Pharmacy signals a pivotal moment for the company's growth trajectory. This capital infusion is expected to fuel further expansion of its compounding services, potentially enabling broader market reach and the development of new therapeutic solutions. Given the company's established history and focus on specialized medications, this backing will likely support enhancements in research and development, operational scaling, and the strengthening of its supply chain to meet increasing demand from both veterinary and human healthcare sectors. Stokes Pharmacy is poised to leverage this financial backing to solidify its leadership in the specialized pharmaceutical compounding industry.
See full Stokes Pharmacy company page
